SCHEMBL2053529

SCHEMBL2053529

NCC1CCCN1CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28774451 0.93 HTT (0.35)
Hydrochloric Acid SCHEMBL10751412 0.91 HTT (0.34)
SCHEMBL28058906 0.84
SCHEMBL9036814 0.83
SCHEMBL132799 0.81
SCHEMBL335433 0.81
SCHEMBL299670 0.81
SCHEMBL14509625 0.81 ALOX15 (0.35)
SCHEMBL14300533 0.81
SCHEMBL7026183 0.79 HTT (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2515648-A1 METHODS FOR THE SYNTHESIS OF POLYCYCLIC GUANIDINE COMPOUNDS Novomer, Inc. (US) 2012-10-31 EP claimed
WO-2011079041-A1 METHODS FOR THE SYNTHESIS OF POLYCYCLIC GUANIDINE COMPOUNDS NOVOMER, INC. (US) 2011-06-30 WO claimed
US-20240417387-A1 SULFONYLPIPERAZINYL COMPOUNDS FOR TREATMENT OF BACTERIAL INFECTIONS HOFFMANN-LA ROCHE INC. (US) 2024-12-19 US disclosed